DDC acquires Orchid Cellmark's government paternity business

NewsGuard 100/100 Score

DDC (DNA Diagnostics Center), one of the largest DNA testing companies in the world, announced today the acquisition of Orchid Cellmark, Inc.'s  (Orchid Cellmark) government paternity business. Orchid Cellmark, a leading international provider of DNA testing services primarily for forensic and family relationship applications, is now a wholly-owned subsidiary of Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH).  

"Our acquisition of Orchid's government paternity business significantly expands the size and scope of DDC's portfolio, further solidifying our position as one of the largest DNA testing companies in the world," said Peter Vitulli, DDC President and CEO. He continued, "This transaction allows for a strong and vibrant competitive landscape in the marketplace, which will in turn benefit the consumer. Orchid's government paternity business has earned an outstanding reputation for excellent quality and reliability, as well as top notch customer service, and we are pleased to enter into this agreement." 

Orchid Cellmark has provided parentage testing services to government agencies since 1979, providing contracts to numerous state and county entities under exclusive and multi-vendor terms.  Some of these contracts and their renewals span more than two decades.   

Source:

DDC

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Baylor study reveals role of newly inherited DNA variants in recessive diseases